Authors:
van de Loosdrecht, AA
Kok, K
de Vries, B
van der Veen, AY
van den Berg, E
Esselink, MT
Marynen, P
Vellenga, E
van Imhoff, GW
Citation: Aa. Van De Loosdrecht et al., Breakpoint analysis by fluorescence in situ hybridization in myelodysplastic syndromes with t(3;12)(q26;p13) and expression of EVI1, LEUKEMIA, 14(10), 2000, pp. 1857-1858
Authors:
van der Kolk, DM
Vellenga, E
van der Veen, AY
Noordhoek, L
Timmer-Bosscha, H
Ossenkoppele, GJ
Raymakers, RA
Muller, M
van den Berg, E
de Vries, EGE
Citation: Dm. Van Der Kolk et al., Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity, BLOOD, 95(11), 2000, pp. 3514-3519
Authors:
van Leeuwen, EBM
van der Veen, AY
Hoekstra, D
Engberts, JBFN
Halie, MR
van der Meer, J
Ruiters, MHJ
Citation: Ebm. Van Leeuwen et al., Transfection of small numbers of human endothelial cells by electroporation and synthetic amphiphiles, EUR J VAS E, 17(1), 1999, pp. 9-14
Authors:
Timmer, T
Terpstra, P
van den Berg, A
Veldhuis, PMJF
Ter Elst, A
van der Veen, AY
Kok, K
Naylor, SL
Buys, CHCM
Citation: T. Timmer et al., An evolutionary rearrangement of the Xp11.3-11.23 region in 3p21.3, a region frequently deleted in a variety of cancers, GENOMICS, 60(2), 1999, pp. 238-240
Authors:
de Graaff, WE
van Echten, J
van der Veen, AY
Sleijfer, DT
Timmer, A
Koops, HS
de Jong, B
Citation: We. De Graaff et al., Loss of the Y-chromosome in the primary metastasis of a male sex cord stromal tumor: Pathogenetic implications, CANC GENET, 112(1), 1999, pp. 21-25